Clinical Trials Logo

Gulf War Illness clinical trials

View clinical trials related to Gulf War Illness.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05820893 Not yet recruiting - Gulf War Illness Clinical Trials

Resistant Potato Starch to Alleviate GWI

Start date: June 3, 2024
Phase: Phase 2
Study type: Interventional

Gulf War Illness (GWI) affects an estimated 25-32% of the over 700,000 coalition troops deployed to the Persian Gulf as part of the First Gulf War. GWI causes a range of pain, fatigue, gastrointestinal, skin, neurologic, and respiratory symptoms. New treatments to reduce GWI-associated morbidity are critically needed. Research suggests a role for the gastrointestinal microbiome in mediating health, including through impacting metabolism and immunity. The disruption of this microbiome plays a role in multiple diseases, and preliminary data suggest that Veterans with GWI have altered gut microbiota. The investigators will evaluate the effectiveness of a dietary fiber prebiotic supplement intervention on improving the quality of life of Veterans with GWI.